Literature DB >> 9817920

Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor.

A Al-Chalabi1, P M Andersen, B Chioza, C Shaw, P C Sham, W Robberecht, G Matthijs, W Camu, S L Marklund, L Forsgren, G Rouleau, N G Laing, P V Hurse, T Siddique, P N Leigh, J F Powell.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive motor neurodegeneration resulting in paralysis and death from respiratory failure within 3-5 years. About 20% of familial cases are associated with mutations in the gene for copper/zinc superoxide dismutase ( SOD1 ), which catalyses the dismutation of the superoxide radical to hydrogen peroxide and oxygen. Experimental evidence suggests mutations act by a toxic gain of function but the mechanism is unknown. There are >60 known SOD1 mutations associated with ALS and all are dominant except for one in exon 4, a D90A substitution which is recessive. D90A pedigrees with dominant inheritance have now been reported and this apparent contradiction needs to be explained. We performed a worldwide haplotype study on 28 D90A pedigrees using six highly polymorphic microsatellite markers. We now show that all 20 recessive families share the same founder (alpha = 0.999), regardless of geographical location, whereas several founders exist for the eight dominant families (alpha = 0.385). This finding confirms that D90A can act in a dominant fashion in keeping with all other SOD1 mutations, but that on one occasion, a new instance of this mutation has been recessive. We propose a tightly linked protective factor which modifies the toxic effect of mutant SOD1 in recessive families.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817920     DOI: 10.1093/hmg/7.13.2045

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  29 in total

Review 1.  Complex genetics of amyotrophic lateral sclerosis.

Authors:  Catherine B Kunst
Journal:  Am J Hum Genet       Date:  2004-10-11       Impact factor: 11.025

2.  A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population.

Authors:  Agnes L Nishimura; Ammar Al-Chalabi; Mayana Zatz
Journal:  Hum Genet       Date:  2005-09-27       Impact factor: 4.132

3.  Wildtype sigma-1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity.

Authors:  Yasuharu Shinoda; Yudai Haga; Koichiro Akagawa; Kohji Fukunaga
Journal:  J Biol Chem       Date:  2020-10-14       Impact factor: 5.157

4.  SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study.

Authors:  Stefania Battistini; Fabio Giannini; Giuseppe Greco; Giuseppe Bibbò; Loreta Ferrera; Valeria Marini; Renzo Causarano; Michela Casula; Giuliana Lando; Maria Cristina Patrosso; Claudia Caponnetto; Paola Origone; Alessandro Marocchi; Alberto Del Corona; Gabriele Siciliano; Paola Carrera; Vincenzo Mascia; Marcello Giagheddu; Carlo Carcassi; Sandro Orrù; Cecilia Garrè; Silvana Penco
Journal:  J Neurol       Date:  2005-03-29       Impact factor: 4.849

Review 5.  The complex molecular biology of amyotrophic lateral sclerosis (ALS).

Authors:  Rachel L Redler; Nikolay V Dokholyan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 6.  TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43.

Authors:  Tania F Gendron; Rosa Rademakers; Leonard Petrucelli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  Age and founder effect of SOD1 A4V mutation causing ALS.

Authors:  M Saeed; Y Yang; H-X Deng; W-Y Hung; N Siddique; L Dellefave; C Gellera; P M Andersen; T Siddique
Journal:  Neurology       Date:  2009-01-28       Impact factor: 9.910

8.  Characterization of intercostal muscle pathology in canine degenerative myelopathy: a disease model for amyotrophic lateral sclerosis.

Authors:  Brandie R Morgan; Joan R Coates; Gayle C Johnson; Alyssa C Bujnak; Martin L Katz
Journal:  J Neurosci Res       Date:  2013-09-16       Impact factor: 4.164

9.  Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS.

Authors:  M R Turner; A D Osei-Lah; A Hammers; A Al-Chalabi; C E Shaw; P M Andersen; D J Brooks; P N Leigh; K R Mills
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

10.  Heterozygous SOD1 D90A mutation presenting as slowly progressive predominant upper motor neuron amyotrophic lateral sclerosis.

Authors:  Marco Luigetti; Amelia Conte; Francesca Madia; Giuseppe Marangi; Marcella Zollino; Irene Mancuso; Michele Dileone; Alessandra Del Grande; Vincenzo Di Lazzaro; Pietro Attilio Tonali; Mario Sabatelli
Journal:  Neurol Sci       Date:  2009-08-15       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.